AbbVie, Takeda and Astellas, along with other major drug companies, have contributed nearly $86 million toward an effort to defeat Proposition 61. That's an Election Day ballot referendum where voters decide yes or no about regulating prices of drugs purchased by some California agencies on behalf of 4.4 million people whose health care is covered by the state.